Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection

Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in people with HIV (PWH) with a history of late presentation (LP) and their durability have not been fully characterized. In this prospective, longitudinal study, we sought to assess T-cell and humoral res...

Celý popis

Podrobná bibliografia

Vydané v:	AIDS (London) Ročník 37; číslo 10; s. 1503
Hlavní autori:	Augello, Matteo, Bono, Valeria, Rovito, Roberta, Tincati, Camilla, d'Arminio Monforte, Antonella, Marchetti, Giulia
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.08.2023
Predmet:	2019-nCoV Vaccine mRNA-1273 Angiotensin-Converting Enzyme 2 Antiretroviral Therapy, Highly Active COVID-19 - prevention & control Cytokines HIV Infections - drug therapy Humans Longitudinal Studies Prospective Studies SARS-CoV-2
ISSN:	1473-5571, 1473-5571
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!